BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 17433503)

  • 1. Alterations in NMDA receptor subunit densities and ligand binding to glycine recognition sites are associated with chronic anxiety in Alzheimer's disease.
    Tsang SW; Vinters HV; Cummings JL; Wong PT; Chen CP; Lai MK
    Neurobiol Aging; 2008 Oct; 29(10):1524-32. PubMed ID: 17433503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ligand affinities at recombinant N-methyl-D-aspartate receptors depend on subunit composition.
    Laurie DJ; Seeburg PH
    Eur J Pharmacol; 1994 Aug; 268(3):335-45. PubMed ID: 7528680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N-Methyl-D-aspartate receptor subunit proteins and their phosphorylation status are altered selectively in Alzheimer's disease.
    Sze C; Bi H; Kleinschmidt-DeMasters BK; Filley CM; Martin LJ
    J Neurol Sci; 2001 Jan; 182(2):151-9. PubMed ID: 11137521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The integrity of the glycine co-agonist binding site of N-methyl-D-aspartate receptors is a functional quality control checkpoint for cell surface delivery.
    Kenny AV; Cousins SL; Pinho L; Stephenson FA
    J Biol Chem; 2009 Jan; 284(1):324-333. PubMed ID: 18990687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-methyl-D-aspartate receptor subunit NR2A and NR2B messenger RNA levels are altered in the hippocampus and entorhinal cortex in Alzheimer's disease.
    Bi H; Sze CI
    J Neurol Sci; 2002 Aug; 200(1-2):11-8. PubMed ID: 12127670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro and in vivo antagonistic activities of SM-31900 for the NMDA receptor glycine-binding site.
    Ohtani K; Tanaka H; Yoneda Y; Yasuda H; Ito A; Nagata R; Nakamura M
    Brain Res; 2002 Jul; 944(1-2):165-73. PubMed ID: 12106676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and characterization of novel NMDA receptor antagonists selective for NR2A- over NR2B-containing receptors.
    Bettini E; Sava A; Griffante C; Carignani C; Buson A; Capelli AM; Negri M; Andreetta F; Senar-Sancho SA; Guiral L; Cardullo F
    J Pharmacol Exp Ther; 2010 Dec; 335(3):636-44. PubMed ID: 20810618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The molecular basis of NMDA receptor subtypes: native receptor diversity is predicted by subunit composition.
    Buller AL; Larson HC; Schneider BE; Beaton JA; Morrisett RA; Monaghan DT
    J Neurosci; 1994 Sep; 14(9):5471-84. PubMed ID: 7916045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for functional native NMDA receptors activated by glycine or D-serine alone in the absence of glutamatergic coagonist.
    Paudice P; Gemignani A; Raiteri M
    Eur J Neurosci; 1998 Sep; 10(9):2934-44. PubMed ID: 9758163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-methyl-D-aspartate receptor complex in the hippocampus of elderly, normal individuals and those with Alzheimer's disease.
    Ułas J; Brunner LC; Geddes JW; Choe W; Cotman CW
    Neuroscience; 1992 Jul; 49(1):45-61. PubMed ID: 1407551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preservation of redox, polyamine, and glycine modulatory domains of the N-methyl-D-aspartate receptor in Alzheimer's disease.
    Palmer AM; Burns MA
    J Neurochem; 1994 Jan; 62(1):187-96. PubMed ID: 8263519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential expression of NMDA and AMPA receptor subunits in rat dorsal and ventral hippocampus.
    Pandis C; Sotiriou E; Kouvaras E; Asprodini E; Papatheodoropoulos C; Angelatou F
    Neuroscience; 2006 Jun; 140(1):163-75. PubMed ID: 16542781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of acute and chronic ethanol exposure on heteromeric N-methyl-D-aspartate receptors expressed in HEK 293 cells.
    Blevins T; Mirshahi T; Chandler LJ; Woodward JJ
    J Neurochem; 1997 Dec; 69(6):2345-54. PubMed ID: 9375665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Manganese inhibits NMDA receptor channel function: implications to psychiatric and cognitive effects.
    Guilarte TR; Chen MK
    Neurotoxicology; 2007 Nov; 28(6):1147-52. PubMed ID: 17662456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subunit arrangement and function in NMDA receptors.
    Furukawa H; Singh SK; Mancusso R; Gouaux E
    Nature; 2005 Nov; 438(7065):185-92. PubMed ID: 16281028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High affinity [3H]dextrorphan binding in rat brain is localized to a noncompetitive antagonist site of the activated N-methyl-D-aspartate receptor-cation channel.
    Franklin PH; Murray TF
    Mol Pharmacol; 1992 Jan; 41(1):134-46. PubMed ID: 1370704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spermine modulation of the glutamate(NMDA) receptor is differentially responsive to conantokins in normal and Alzheimer's disease human cerebral cortex.
    Ragnarsson L; Mortensen M; Dodd PR; Lewis RJ
    J Neurochem; 2002 May; 81(4):765-79. PubMed ID: 12065636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Binding to the glycine site of the NMDA receptor complex in brains of patients with Alzheimer's disease.
    Del Bel EA; Slater P
    Neurosci Lett; 1991 Sep; 131(1):75-8. PubMed ID: 1838796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein kinase C enhances glycine-insensitive desensitization of NMDA receptors independently of previously identified protein kinase C sites.
    Jackson MF; Konarski JZ; Weerapura M; Czerwinski W; MacDonald JF
    J Neurochem; 2006 Mar; 96(6):1509-18. PubMed ID: 16417568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased NR1, NR2A, and SAP102 transcript expression in the hippocampus in bipolar disorder.
    McCullumsmith RE; Kristiansen LV; Beneyto M; Scarr E; Dean B; Meador-Woodruff JH
    Brain Res; 2007 Jan; 1127(1):108-18. PubMed ID: 17113057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.